Biorestorative Therapies (NASDAQ:BRTX) Trading 5.9% Higher – Time to Buy?

Biorestorative Therapies, Inc. (NASDAQ:BRTX)’s share price shot up 5.9% during trading on Friday . The company traded as high as $0.2873 and last traded at $0.26. 45,434,601 shares traded hands during trading, an increase of 4,766% from the average session volume of 933,692 shares. The stock had previously closed at $0.2455.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Biorestorative Therapies in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Biorestorative Therapies Price Performance

The firm’s 50-day simple moving average is $1.08 and its 200 day simple moving average is $1.33. The firm has a market capitalization of $2.31 million, a price-to-earnings ratio of -0.18 and a beta of 0.39.

Biorestorative Therapies (NASDAQ:BRTX) last issued its earnings results on Wednesday, November 12th. The company reported ($0.38) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.38). Biorestorative Therapies had a negative return on equity of 231.08% and a negative net margin of 3,308.09%.The firm had revenue of $0.01 million for the quarter, compared to the consensus estimate of $0.46 million. As a group, research analysts predict that Biorestorative Therapies, Inc. will post -1.43 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of BRTX. DRW Securities LLC bought a new position in shares of Biorestorative Therapies in the fourth quarter worth about $55,000. Citadel Advisors LLC bought a new stake in shares of Biorestorative Therapies during the 3rd quarter valued at approximately $152,000. Finally, Virtu Financial LLC increased its position in Biorestorative Therapies by 102.4% during the 3rd quarter. Virtu Financial LLC now owns 24,351 shares of the company’s stock worth $35,000 after purchasing an additional 12,319 shares in the last quarter. Institutional investors own 69.38% of the company’s stock.

Biorestorative Therapies Company Profile

Biorestorative Therapies Inc (NASDAQ: BRTX) is a clinical-stage biopharmaceutical company focused on the development and commercialization of regenerative tissue therapy products. The company leverages a proprietary universal allogeneic cell technology platform to create high-potency cell therapy candidates designed to promote tissue repair, reduce inflammation and accelerate healing in areas damaged by disease or medical treatment.

Its lead development program targets radiation-induced oral mucositis (RIOM), a painful and dose-limiting side effect experienced by head and neck cancer patients undergoing radiotherapy.